secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucira Health, Inc. (—)
CIK:        0001652724
Form:       8-K
Filed at:   2023-09-25T23:59:59+00:00
Accession:  0001193125-23-241312
Event type: other_material
Sentiment:  negative
Materiality: 0.95
Item codes: 1.03, 8.01, 3.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bankruptcy court confirms Lucira Health's Chapter 11 liquidation plan; equity cancelled
--------------------------------------------------------------------------------

- Confirmation Order entered Sept 19, 2023; all 41,763,433 common shares will be cancelled on Effective Date.
- Pfizer purchased substantially all assets in April 2023; proceeds go to a liquidating trust for allowed claims.
- Brian Ryniker appointed Liquidating Trustee; CEO, CFO, and one director resign on Effective Date.
- Holders of equity interests receive no distribution under the liquidation plan.
- Company holds ~$565k employee retention credit claim; August 2023 monthly operating report filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652724/000119312523241312/0001193125-23-241312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652724/000119312523241312/d538189d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-241312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer